Biocentury reporters

Author: evme

August undefined, 2024

WebAug 16, 2012 · The first 100 shows of BioCentury This Week have included a two-part debate on scientific risk and regulatory risk featuring Dr. Janet Woodcock of FDA and Wall Street's Jonathan Leff of Warburg Pincus; a discussion on the future of translational science in the laboratory of NIH Director Dr. Francis Collins; and new thinking being brought to … WebBioCentury's new Distillery Dashboard unifies our curated collection of translational innovation in a searchable database, making it easy to explore biological and …

BioCentury - Home

WebBioCentury's Distillery Dashboard is a searchable database summarizing translational papers from over 25 top journals, with new innovations added continuously. Search for targets, diseases and geographies of interest, … WebHeather McKenzie is a professional journalist with more than five years experience in the biopharmaceutical industry. Since joining BioSpace, she has written more than 200 … screening and signaling

ASPIRE Internship: Science Writer Intern, Editorial Department ...

WebCommissioned for the BioCentury China Healthcare Summit, this report discusses recent trends impacting the short- and long-term potential of the China pharmaceuticals market. The report explores root causes of the market slow-down observed in 2015, and assesses China's latest policy developments meant to better support innovation. WebFounded Date 1993. Founders David Flores. Operating Status Active. Company Type For Profit. Contact Email [email protected]. Phone Number 650-595-5333. Since 1993, BioCentury Publications, Inc. has been internationally recognized as the leading provider of value-added information, analysis and data for biotechnology and pharmaceutical ... WebApr 30, 2024 · When McKinsey and BioCentury interviewed representatives from 106 biotech companies in May 2024, 4 See “COVID-19: Reimagining biotech in 2024,” webinar, BioCentury, July 8, 2024, biocentury.com. half of those interviewed were expecting delays in financing, and about 80 percent were tight on cash for the next two years and … screening aortenaneurysma ziffer

Biocentury reporters

WebSeasoned journalist, writer, and editor with deep expertise in creating informative, engaging content. Specialties: content strategy, … WebI lead Business Development, International Strategy and C-level Conferences for BioCentury. I am responsible for building our corporate …

Did you know?

WebNov 19, 2024 · Maha Katabi, Ph.D. "Sofinnova Investments and BioCentury share a deep commitment to make a positive impact in the biotech community. We are proud to be a … WebSep 8, 2015 · BioCentury Publications Inc. today announced that Karen Bernstein, Ph.D., has stepped down as Editor-in-Chief to devote full time to corporate development as Chairman of the company she co-founded ...

WebBioCentury's Editorial and Research staff comprise industry-recognized business and science editors and writers. The Company's management team includes executives with … WebApr 10, 2024 · Gilead CMO expands on his pipeline rationale, biotech challenges and where step changes might come: The BioCentury Show. New therapies continue to raise efficacy bar in hidradenitis suppurativa. Bimzelx has best Phase III data yet, but earlier stage competitors hitting higher efficacy thresholds.

WebNaturally occurring protein switches have been repurposed for the development of biosensors and reporters for cellular and clinical applications 1 . However, the number of such switches is limited, and reengineering them is challenging. ... KAIST Institute for the Biocentury, Korea Advanced Institute of Science and Technology, Daejeon, South ... WebUpdates. BioCentury Inc. 6,241 followers. 2mo. Now in our 23rd year, Bio€quity heads to Dublin, Ireland, May 14-16, 2024, with a program focused on how to create a new playbook for biotech ...

WebApr 6, 2016 · Description: BioCentury is the Company's flagship publication, serving a worldwide audience in the biopharma, investment and public policy communities. This audience values BioCentury's … screening and shortlistingWebBioCentury's new Distillery Dashboard unifies our curated collection of translational innovation in a searchable database, making it easy to explore biological and technological white space, and identify the key investigators driving the innovations. Explore the interactive Distillery Dashboard. screening aorta ebmWebSep 4, 2012 · BioCentury also produces its BioCentury This Week biotech public affairs television program in partnership with the Gannett-owned WUSA9 CBS affiliate in Washington, D.C. The program is aired in Washington each Sunday as part of the WUSA9 Sunday Morning Power Block, on Public Broadcasting System member stations in … screening aostaWebBy Lauren Martz. BioCentury. AACR data hint BioNTech on path to clearing two industry hurdles Early data for BNT211 show German biotech’s progress in applying CAR T cells … screening apo portalWebBioCentury's Analysts & Research Team is comprised of industry-recognized business and science editors, writers and analysts, delivering trusted intelligence 24/7. Analysts & … BioCentury was founded 30 years ago by Karen Bernstein and David Flores to … screening aortenaneurysmaWebMar 27, 2024 · BioCentury’s editors also discuss the proposed $43 billion acquisition of Seagen by Pfizer, takeaways from CDER Director Patrizia Cavazzoni’s conversation with Washington Editor Steve Usdin on The … screening applicantsWebMay 27, 2024 · ASPIRE Internship: Science Writer Intern, Editorial Department, BioCentury Inc., (remote). BioCentury is looking for interns in a part-time role to write brief summaries of translationally relevant preclinical studies from top biomedical journals for our monthly Distillery feature. The position requires a minimum of 10 hours of work per week, … screening aortic aneurysm cpt